HF Sinclair Corporation · DINO · FY2025 Q3 · Calendar Q4 2025
HF Sinclair cites low refinery costs, advances West Coast projects
The supplied Q3 analysis supports a constructive operating picture: refinery efficiency and throughput were strong, while proposed projects target West Coast demand. The case remains exposed to regulatory outcomes, refining-market volatility, and project execution and financing.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about DINO FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, Q3 emphasized record-low refinery operating expense and near-record throughput, added detail on CARB gasoline, jet-fuel flexibility and pipeline expansion initiatives, and highlighted benefits from small-refinery exemptions and RIN trading. Guidance was described as maintained.
Guidance delta
Management maintained guidance for Q4 refining margins and 2025 capital spending; the supplied analysis characterizes the outlook as confident.
Key takeaways
- Refinery operating expense reached a record low and throughput was near-record, according to the supplied Q3 analysis.
- Management highlighted CARB gasoline and jet-fuel flexibility projects at Puget Sound, plus a phased pipeline expansion under evaluation.
- Small-refinery exemptions and RIN trading contributed margin benefits in Q3; continued benefit depends on regulatory and market conditions.
- Management reported returning capital to shareholders and maintaining its dividend policy while pursuing organic growth.
Management priorities
- Complete the CARB gasoline project at the Puget Sound refinery.
- Commission the jet-fuel flexibility project after the Puget Sound turnaround.
- Advance Phase 1 of the pipeline expansion, targeted for 2028, and evaluate additional capacity phases.
- Maintain shareholder returns while pursuing organic growth.
Follow DINO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 22, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 14, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 12, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 9, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 8, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Apr 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 23, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 19, 2026 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | Jul 14, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Dec 10, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Mar 15, 2024 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | May 11, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $113.92. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Justin Jenkins | $150 | $111.96 | +31.7% | Oct 28, 2026 |
| Raymond James | Justin Jenkins | $160 | $114.21 | +40.4% | Oct 28, 2026 |
| Piper Sandler | Analyst unavailable | $152 | $125.25 | +33.4% | Oct 27, 2026 |
| Wells Fargo | Analyst unavailable | $135 | $128.23 | +18.5% | Oct 14, 2026 |
| Goldman Sachs | Analyst unavailable | $142 | $120.72 | +24.6% | Oct 9, 2026 |
| Mizuho Securities | Analyst unavailable | $119 | $115.63 | +4.5% | Oct 8, 2026 |
| UBS | Analyst unavailable | $133 | $113.36 | +16.7% | Oct 3, 2026 |
| Raymond James | Analyst unavailable | $140 | $105.85 | +22.9% | Sep 14, 2026 |
| Morgan Stanley | Analyst unavailable | $127 | $111.17 | +11.5% | Sep 14, 2026 |
| UBS | Manav Gupta | $126 | $105.41 | +10.6% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $93 | $101.61 | -18.4% | Sep 1, 2026 |
| Mizuho Securities | Nitin Kumar | $85 | $87.26 | -25.4% | Aug 4, 2026 |
| Goldman Sachs | Analyst unavailable | $114 | $90 | +0.1% | Jul 29, 2026 |
| Barclays | Theresa Chen | $86 | $89.3 | -24.5% | Jul 29, 2026 |
| Raymond James | Justin Jenkins | $105 | $89.3 | -7.8% | Jul 29, 2026 |
| Raymond James | Analyst unavailable | $95 | $80.97 | -16.6% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $81 | $78.07 | -28.9% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $78 | $69.9 | -31.5% | Jun 12, 2026 |
| Mizuho Securities | Nitin Kumar | $79 | $68.53 | -30.7% | May 27, 2026 |
| Goldman Sachs | Analyst unavailable | $81 | $74.5 | -28.9% | May 6, 2026 |
| UBS | Analyst unavailable | $80 | $72.65 | -29.8% | May 5, 2026 |
| Cowen & Co. | Analyst unavailable | $80 | $70.16 | -29.8% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $69 | $70.13 | -39.4% | May 4, 2026 |
| Barclays | Theresa Chen | $71 | $69.17 | -37.7% | May 4, 2026 |
| Morgan Stanley | Joe Laetsch | $66 | $59.54 | -42.1% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $61 | $58.56 | -46.5% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $60 | $50.86 | -47.3% | Feb 23, 2026 |
| Morgan Stanley | Analyst unavailable | $57 | $51.02 | -50.0% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $63 | $51.57 | -44.7% | Feb 19, 2026 |
| Scotiabank | Paul Cheng | $53 | $51.57 | -53.5% | Feb 18, 2026 |
| Morgan Stanley | Joe Laetsch | $61 | $49.35 | -46.5% | Jan 27, 2026 |
| Scotiabank | Paul Cheng | $62 | $48.83 | -45.6% | Jan 16, 2026 |
| Piper Sandler | Analyst unavailable | $67 | $49.82 | -41.2% | Jan 16, 2026 |
| Piper Sandler | Analyst unavailable | $68 | $48.18 | -40.3% | Jan 8, 2026 |
| Mizuho Securities | Nitin Kumar | $63 | $49.36 | -44.7% | Dec 12, 2025 |
| UBS | Manav Gupta | $65 | $53.39 | -42.9% | Nov 4, 2025 |
| Raymond James | Analyst unavailable | $65 | $50.63 | -42.9% | Oct 17, 2025 |
| Scotiabank | Paul Cheng | $66 | $52.44 | -42.1% | Oct 9, 2025 |
| Morgan Stanley | Joe Laetsch | $60 | $51.84 | -47.3% | Oct 3, 2025 |
| UBS | Analyst unavailable | $63 | $51.99 | -44.7% | Oct 2, 2025 |
| UBS | Analyst unavailable | $54 | $52.34 | -52.6% | Oct 1, 2025 |
| Mizuho Securities | Nitin Kumar | $60 | $51.64 | -47.3% | Sep 15, 2025 |
| Raymond James | Analyst unavailable | $60 | $52.43 | -47.3% | Sep 9, 2025 |
| UBS | Manav Gupta | $58 | $49.22 | -49.1% | Aug 26, 2025 |
| Barclays | Theresa Chen | $43 | $44.74 | -62.3% | Jul 9, 2025 |
| Barclays | Analyst unavailable | $35 | $32.36 | -69.3% | Mar 14, 2025 |
| Piper Sandler | Analyst unavailable | $46 | $32.13 | -59.6% | Mar 7, 2025 |
| Wells Fargo | Roger Read | $53 | $44.51 | -53.5% | Oct 8, 2024 |
| Piper Sandler | Ryan Todd | $49 | $47.25 | -57.0% | Sep 20, 2024 |
| Barclays | Theresa Chen | $53 | $46.76 | -53.5% | Aug 5, 2024 |
| Barclays | Theresa Chen | $56 | $53.34 | -50.8% | Jul 1, 2024 |
| Mizuho Securities | Nitin Kumar | $61 | $52.14 | -46.5% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $58 | $52.17 | -49.1% | Jun 14, 2024 |
| Piper Sandler | Ryan Todd | $65 | $56.21 | -42.9% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $65 | $60 | -42.9% | Apr 15, 2024 |
| Piper Sandler | Ryan Todd | $70 | $62.9 | -38.6% | Apr 5, 2024 |
| UBS | Manav Gupta | $73 | $59.52 | -35.9% | Feb 14, 2024 |
| BMO Capital | Phillip Jungwirth | $65 | $52.49 | -42.9% | Oct 5, 2023 |
| Wells Fargo | Analyst unavailable | $55 | $50.52 | -51.7% | Jan 5, 2023 |
| Piper Sandler | Analyst unavailable | $75 | $50.76 | -34.2% | Dec 19, 2022 |
| Barclays | Analyst unavailable | $56 | $50.75 | -50.8% | Aug 16, 2022 |
| Barclays | Analyst unavailable | $51 | $45.65 | -55.2% | Jul 5, 2022 |
| Goldman Sachs | Neil Mehta | $53 | $45 | -53.5% | Jun 21, 2022 |
| Credit Suisse | Analyst unavailable | $53 | $42.29 | -53.5% | May 10, 2022 |
Track every rating change on DINO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHF Sinclair Corporation operates as a prominent independent energy enterprise, engaged in the production and commercialization of a diverse array of petroleum products. Its offerings include conventional fuels such as gasoline, diesel, and jet fuel, alongside its growing renewable diesel segment. The company also specializes in unique lubricants, chemicals, and various types of asphalt. With a network of refineries strategically located in Kansas, Oklahoma, New Mexico, Utah, Washington, and Wyoming, HF Sinclair primarily distributes its refined output across the Southwestern United States, the Rocky Mountain…
Historical context
All DINO earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.4% | +1.8% | Chevron posts strong Q3 as production, cash flow and AI value rise |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.2% | ExxonMobil Highlights Refining, LNG and Cash Returns in Q3 |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | +6.4% | +5.5% | Imperial Oil: downstream strength and low-carbon growth lead Q3 |
| CCJ Cameco Corporation | FY2026 Q3 · Calendar Q4 2026 | -101.4% | -7.9% | Cameco keeps nuclear-growth thesis intact as Key Lake outage weighs |
| BP BP p.l.c. | FY2026 Q3 · Calendar Q4 2026 | +22.6% | +0.1% | BP Q3: Strong profit, lower debt, safety risks persist |
Latest beats and misses
Who reports nextBeat on EPS
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
- CLXFY2027 Q1 · November 2, 2026+44.9% EPS+2.2% move
- AAPLFY2026 Q4 · November 2, 2026+3.0% EPS-1.8% move
- PLTRFY2026 Q3 · November 2, 2026+8.3% EPS-3.1% move
- ETRFY2026 Q3 · November 2, 2026+14.5% EPS-0.2% move
- OFY2026 Q3 · November 2, 2026+5.7% EPS+1.1% move
Missed on EPS
- VRTXFY2026 Q3 · November 2, 2026-1.2% EPS-1.0% move
- PEGFY2026 Q3 · November 2, 2026-3.4% EPS+0.1% move
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
Get the DINO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-03T13:30:48.312086+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T13:30:48.309436+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.